European Commission to Simplify the Procedures for Taking Part in EU-funded Research Projects

The overall aim is to make participation transparent and attractive to the best researchers and innovative companies in Europe and beyond. Ensuring European research realises its full potential is crucial to the EU's Europe 2020 Strategy, given the need to consolidate economic recovery and develop new sources of growth and jobs to replace those lost in the crisis. Complementing the proposals on simplification, the Commission has also appointed a group of independent experts to review all aspects of the current Seventh Framework Programme.

Research, Innovation and Science Commissioner Máire Geoghegan-Quinn said: "Our proposals aim to minimise administrative burdens in Europe's research programmes. We need to get the best researchers and most innovative companies taking part and we need to enable them to concentrate on results, not red tape. That will boost Europe's economy and quality of life. In particular, we must encourage more SME's to join in. I believe this can be done without compromising financial control. We are asking the other EU institutions for support to achieve this."

Budget Commissioner Janusz Lewandowski added: "The review of the Financial regulation which the Commission will present next month will underpin these ideas for simplifying research funding with concrete legal proposals, helpful also in many other policy areas. We need simpler rules to encourage potential beneficiaries of EU funds - such as small and medium enterprises or NGOs - to apply for them. Simplification means the EU budget serving citizens and businesses better."

The first part of the Commission's strategy will make improvements possible under the current legal and regulatory framework, some of which are already underway. These involve, for example, better IT systems, more consistent application of rules, in particular on auditing, and improving the structure and content of the "calls for proposals" in response to which research organisations bid for funding.

The second part involves changing the existing financial rules to allow more radical simplification while maintaining effective control, for example by widening the use of "average cost methodologies" that avoid the need for projects to account separately and painstakingly for each small item of expenditure. The Commission also aims to allow projects to use the same accounting methods for EU funding as they are required to use for national research funding. These proposals require a decision of the European Parliament and the Council.

The third type of change envisaged will be considered for implementation under future Research Framework Programmes. Among the options presented is a move towards "payment by results", which would mean that beneficiaries were paid lump sums to undertake specific scientific tasks and would need to demonstrate that they have done so effectively and efficiently, rather than to report individual cost items.

In the meantime, the Commission has launched the interim evaluation of the current Programme (FP7). A group of independent experts, chaired by Mr. Rolf Annerberg, has been appointed to undertake this review and present their report this autumn.

Mr Annerberg is Director General of the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas). The mandate of the group covers a wide range of issues related to the design, implementation and impact of Framework Programme activities.

Background
FP7 has proved very attractive to the research community with more than 33,000 proposals received since 2007, almost 7000 projects funded. Nearly all European universities participate.

Several concrete steps have already been taken towards simplification of procedures both in setting up FP 7 and since it has been in progress.

For example, FP7 introduced a new Guarantee Fund and a single registration facility meaning organisations applying for funding for several projects over several years need only enter their details once. Eight out of ten participants in FP7 are now exempt from ex-ante financial capacity checks and three out of four participants are exempt from providing certificates on financial statements needed for periodic cost claims.

Two new Executive Agencies were set up by the Commission in 2007: the Research Executive Agency (REA) and the European Research Council Executive Agency (ERC-EA). The European Research Council is a flagship component of FP 7 and awards grants to projects headed by starting and established researchers, with no requirement for projects to involve cross-border consortia.

For further information, please visit:
http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...